The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints

A MedCity News analysis examines how patent strategy, FDA regulation, and HIPAA privacy requirements create competing pressures for healthcare AI developers. The piece argues that vendors who align these three legal frameworks from inception—rather than addressing them sequentially—will gain competitive advantage in bringing AI-enabled medical devices and software to market.